YING ZHANG: Open Payments
NPI 1982174504 · ARCADIA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$313 in 13 payments from 7 companies in 2025. Trend: 2023 $62 · 2024 $149 · 2025 $313
Food & beverage: $313
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 3 | $81 |
| Vanda Pharmaceuticals Inc. | 2 | $52 |
| Lilly USA, LLC | 2 | $48 |
| Alvogen Inc | 2 | $40 |
| Corcept Therapeutics | 2 | $37 |
| Neurocrine BioSciences, Inc. | 1 | $30 |
| Novo Nordisk Inc | 1 | $26 |
Products named: AUSTEDO XR, FANAPT, TERIPARATIDE, Korlym, INGREZZA, Ozempic, MOUNJARO, JARDIANCE.
Industry payments across CA — which companies pay providers there.
